Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of RK-582 in unresectable metastatic colorectal cancer
jRCT2031240702Phase 1Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of RK-582 in colorectal cancer (CRC), sponsored by Japan Agency for Medical Research and Development. Started Mar 2025; status: recruiting.
02
Drugs
RK-582
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2031240702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240702.